Texas Awarded $4.7 Million in Shire Pharmaceuticals Medicaid Fraud Investigation

The federal government and 48 state attorney generals, including Texas Attorney General Greg Abbot, resolved a Medicaid fraud investigation with a $56.5 million agreement.

The investigation was being conducted into Shire Pharmaceuticals LLC for unlawfully promoting Adderrall XR, Vyvanse, Daytrona, Lialda and Pentasa. Texas will receive $4.78 million from the settlement.

According to the attorney general’s office, Shire violated state consumer protection laws by misrepresenting the uses and qualities of its intestinal inflammation drugs.

The National Association of Medicaid Fraud Control Unit conducted the investigation and subsequent settlement and included state attorney generals from California, Indiana, Michigan and New York.